Patient info Open main menu

RevitaCAM - patient leaflet, side effects, dosage

Contains active substance :

Dostupné balení:

Patient leaflet - RevitaCAM

,O

  • 9. ADVICE ON CORRECT ADMINISTRATION

Particu1ar care shou1d be taken with regard to the accuracy of dosing. P1ease carefu11y fo11ow the instructions of the veterinarian.

  • 10. WITHDRAWAL PERIOD

Not app1icab1e.

  • 11. SPECIAL STORAGE PRECAUTIONS

Keep out of the sight and reach of chi1dren.

This veterinary medicina1 product does not require any specia1 storage conditions.

She1f-1ife after first opening the container: 6 months.

Do not use this veterinary medicina1 product after the expiry date which is stated on the carton and the via1.

  • 12. SPECIAL WARNING(S)

Special precautions for use in animals:

If adverse reactions occur, treatment should be discontinued and the advice of the veterinarian should be sought.

Avoid use in any dehydrated, hypovolaemic or hypotensive animal, as there is a potential risk of increased renal toxicity.

  • C -, . u u.u ..U.

Special precautions to be taken by the person administering the veterinary medicinal product to animals:

Wash hands after administration of the product.

People with known hypersensitivity to NSAIDs should avoid contact with the veterinary medicinal product.

Avoid direct contact between the product and skin, if accidental exposure occurs wash hands immediately with soap and water.

Use during pregnancy and lactation:

See section „Contraindica­tions“.

Interactions with other medicinal products and other forms of interaction:

Other NSAIDs, diuretics, anticoagulants, aminoglycoside antibiotics and substances with high protein binding may compete for binding and thus lead to toxic effects. RevitaCAM must not be administered in conjunction with other NSAIDs or glucocorticos­teroids.

Pre-treatment with anti-inflammatory substances may result in additional or increased adverse effects and accordingly a treatment-free period with such veterinary medicinal products should be observed for at least 24 hours before commencement of treatment. The treatment-free period, however, should take into account the pharmacological properties of the products used previously.

Overdose (symptoms, emergency procedures, antidotes) :

In case of overdose symptomatic treatment should be initiated.

  • 13. SPECIAL PRECAUTIONS FOR THE DISPOSAL OF UNUSED PRODUCT OR WASTE MATERIALS, IF ANY

    Medicines should not be disposed of via wastewater or household waste but in accordance with local


Medicines should not be disposed of via wastewater or household waste but in accordance with loc requirements. Ask your veterinary surgeon how to dispose of medicines no longer required. These measures should help to protect the environment.

  • 14. DATE ON WHICH THE PACKAGE LEAFLET WAS LAST APPROVED

Detailed information on this product is available on the website of the European Medicines Agency.

  • 15. OTHER INFORMATION

    10 ml glass vial